Causal Metabolomic and Lipidomic Analysis of Circulating Plasma Metabolites in Autism: A Comprehensive Mendelian Randomization Study with Independent Cohort Validation
Open Access
- 17 October 2024
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (10) , 557
Abstract
Background: The increasing prevalence of autism spectrum disorder (ASD) highlights the need for objective diagnostic markers and a better understanding of its pathogenesis. Metabolic differences have been observed between individuals with and without ASD, but their causal relevance remains unclear. Methods: Bidirectional two-sample Mendelian randomization (MR) was used to assess causal associations between circulating plasma metabolites and ASD using large-scale genome-wide association study (GWAS) datasets—comprising 1091 metabolites, 309 ratios, and 179 lipids—and three European autism datasets (PGC 2015: n = 10,610 and 10,263; 2017: n = 46,351). Inverse-variance weighted (IVW) and weighted median methods were employed, along with robust sensitivity and power analyses followed by independent cohort validation. Results: Higher genetically predicted levels of sphingomyelin (SM) (d17:1/16:0) (OR, 1.129; 95% CI, 1.024–1.245; p = 0.015) were causally linked to increased ASD risk. Additionally, ASD children had higher plasma creatine/carnitine ratios. These MR findings were validated in an independent US autism cohort using machine learning analysis. Conclusion: Utilizing large datasets, two MR approaches, robust sensitivity analyses, and independent validation, our novel findings provide evidence for the potential roles of metabolomics and circulating metabolites in ASD diagnosis and etiology.Keywords
Funding Information
- Macao Polytechnic University (RP/FCA-14/2023, 0033/2023/RIB2)
- Science and Technology Development Funds (FDCT) of Macao (RP/FCA-14/2023, 0033/2023/RIB2)
This publication has 31 references indexed in Scilit:
- Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)Brain, Behavior, and Immunity, 2022
- Plasma and Fecal Metabolite Profiles in Autism Spectrum DisorderBiological Psychiatry, 2021
- Biomarkers in autism spectrum disorders: Current progressClinica Chimica Acta, 2020
- Potential for Digital Behavioral Measurement Tools to Transform the Detection and Diagnosis of Autism Spectrum DisorderJAMA Pediatrics, 2019
- Autism Spectrum Disorder: Incidence and Time Trends Over Two Decades in a Population-Based Birth CohortJournal of Autism and Developmental Disorders, 2018
- Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesisBioEssays, 2017
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcomeStatistics in Medicine, 2015
- AutismThe Lancet, 2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013